Literature DB >> 23760632

Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?

Caroline Rousseau, Françoise Kraeber-Bodéré, Jacques Barbet, Jean-François Chatal.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23760632     DOI： 10.1007/s00259-013-2469-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  20 in total

1.  Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.

Authors:  Edmund A Rossi; David M Goldenberg; Thomas M Cardillo; William J McBride; Robert M Sharkey; Chien-Hsing Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.

Authors:  Rafke Schoffelen; Winette T A van der Graaf; Gerben Franssen; Robert M Sharkey; David M Goldenberg; William J McBride; Edmund A Rossi; Annemarie Eek; Wim J G Oyen; Otto C Boerman
Journal:  J Nucl Med       Date:  2010-11       Impact factor: 10.057

3.  Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

Authors:  F Kraeber-Bodéré; S Bardet; C A Hoefnagel; M R Vieira; J P Vuillez; A Murat; T C Ferreira; M Bardiès; L Ferrer; I Resche; E Gautherot; E Rouvier; J Barbet; J F Chatal
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

4.  Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.

Authors:  Torsten Liersch; Johannes Meller; Bettina Kulle; Thomas M Behr; Peter Markus; Claus Langer; B Michael Ghadimi; William A Wegener; Jacqueline Kovacs; Ivan D Horak; Heinz Becker; David M Goldenberg
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

5.  Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.

Authors:  Eric Frampas; Catherine Maurel; Patricia Remaud-Le Saëc; Thibault Mauxion; Alain Faivre-Chauvet; François Davodeau; David M Goldenberg; Manuel Bardiès; Jacques Barbet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-20       Impact factor: 9.236

6.  Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Authors:  E Gautherot; E Rouvier; L Daniel; E Loucif; J Bouhou; C Manetti; M Martin; J M Le Doussal; J Barbet
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

7.  Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.

Authors:  Thomas M Behr; Torsten Liersch; Lutz Greiner-Bechert; Frank Griesinger; Martin Béhé; Peter M Markus; Stefan Gratz; Christa Angerstein; Gerhard Brittinger; Heinz Becker; David M Goldenberg; Wolfgang Becker
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

8.  High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer.

Authors:  E Mirallié; J P Vuillez; S Bardet; E Frampas; B Dupas; L Ferrer; A Faivre-Chauvet; A Murat; B Charbonnel; J Barbet; D M Goldenberg; J F Chatal; F Kraeber-Bodéré
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

9.  Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.

Authors:  Pierre-Yves Salaun; Loïc Campion; Claire Bournaud; Alain Faivre-Chauvet; Jean-Philippe Vuillez; David Taieb; Catherine Ansquer; Caroline Rousseau; Françoise Borson-Chazot; Stéphane Bardet; Aurore Oudoux; Bertrand Cariou; Eric Mirallié; Chien-Hsing Chang; Robert M Sharkey; David M Goldenberg; Jean-François Chatal; Jacques Barbet; Françoise Kraeber-Bodéré
Journal:  J Nucl Med       Date:  2012-06-28       Impact factor: 10.057

10.  Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Authors:  Rafke Schoffelen; Winette Ta van der Graaf; Robert M Sharkey; Gerben M Franssen; William J McBride; Chien-Hsing Chang; Peter Laverman; David M Goldenberg; Wim Jg Oyen; Otto C Boerman
Journal:  EJNMMI Res       Date:  2012-01-27       Impact factor: 3.138
View more
  1 in total

1.  86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.

Authors:  Emily B Ehlerding; Carolina A Ferreira; Eduardo Aluicio-Sarduy; Dawei Jiang; Hye Jin Lee; Charles P Theuer; Jonathan W Engle; Weibo Cai
Journal:  Mol Pharm       Date:  2018-05-30       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.